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Abstract
Background: Some herpesviruses like human cytomegalovirus (HCMV) encode viral G protein-coupled receptors
that cause reprogramming of cell signaling to facilitate dissemination of the virus, prevent immune surveillance and
establish life-long latency. Human GPCRs are known to function in complex signaling networks involving direct
physical interactions as well as indirect crosstalk of orthogonal signaling networks. The human chemokine receptor
CXCR4 is expressed on hematopoietic stem cells, leukocytes, endothelial and epithelial cells, which are infected by
HCMV or display reservoirs of latency.
Results: We investigated the potential heteromerization of US28 with CXCR4 as well as the influence of US28 on
CXCR4 signaling. Using Bioluminescence Resonance Energy Transfer and luciferase-complementation based methods
we show that US28 expression exhibits negative effects on CXCR4 signaling and constitutive surface expression in
HEK293T cells. Furthermore, we demonstrate that this effect is not mediated by receptor heteromerization but via
signaling crosstalk. Additionally, we show that in HCMV, strain TB40E, infected HUVEC the surface expression of CXCR4
is strongly downregulated, whereas in TB40E-delUS28 infected cells, CXCR4 surface expression is not altered in
particular at late time points of infection.
Conclusions: We show that the vGPCR US28 is leading to severely disturbed signaling and surface expression of the
chemokine receptor CXCR4 thereby representing an effective mechanism used by vGPCRs to reprogram host cell
signaling. In contrast to other studies, we demonstrate that these effects are not mediated via heteromerization.
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Plain English Summary
Some herpesviruses like human cytomegalovirus encode
viral G protein-coupled receptors. These membrane re-
ceptors facilitate dissemination of the virus and often
prevent immune surveillance. As we demonstrate in this
work, the G protein-coupled receptor US28 of HCMV is
able to severely disturb the signaling and surface expres-
sion of the human chemokine receptor CXCR4 and thus
limit the immune response.
Background
Certain herpesviruses like human cytomegalovirus
(HCMV), Epstein-Barr virus (EBV) and Kaposi’s sarcoma-
associated herpesvirus (KSHV) are known to encode viral
G protein-coupled receptors (vGPCRs) [1, 2]. These
vGPCRs had most probably been hijacked from the hu-
man genome as they resemble human GPCRs in structure
and function. HCMV-encoded vGPCRs have previously
been shown to interact with the signaling machinery of
the host cell in a remarkably efficient manner [3]. This re-
programming of cell signaling by vGPCRs is often aimed
at facilitating dissemination of the virus, preventing im-
mune surveillance and establishing life-long latency [4].
HCMV encodes four vGPCRs, US27, US28, UL33 and
UL78, among which US28 is the best-characterized. US28
plays a crucial role in the viral life cycle by promoting viral
spread [5] and by activating the immediate early HCMV
promoter [6], which is necessary for the transactivation of
other viral genes. US28, which is constitutively active, can
also bind to a wide range of chemokines [7], possibly act-
ing as a “chemokine sink” to reduce immune responses at
the site of inflammation [8]. Alternatively, the constitutive
or chemokine-induced signaling activities of US28 may
modulate intracellular signaling pathways consequently
promoting virus replication. In addition, US28 was re-
ported to act as a HIV coreceptor in certain cell types [9]
and has been associated with pathogenic processes leading
to atherosclerosis [10].
Host responses to viral infections involve complex in-
teractions between chemokines and other cytokines that
provide key communication signals resulting in the ef-
fective development of innate and adaptive immunity.
Thus, innate immune responses are critical in limiting
viral spread and averting virus-induced disease. The hu-
man chemokine receptor CXCR4 is a promising target
for manipulation by vGPCRs as it is expressed on cells,
which are infected by HCMV or display reservoirs of la-
tency [11]. CXCR4 is specific for stromal cell-derived
factor-1α (SDF-1α or CXCL12) and is highly expressed
on hematopoietic stem and progenitor cells (HSPCs) in
the bone marrow niche as well as on differentiated cir-
culating blood cells [11]. It serves as a coreceptor for the
cell entry of HIV [12], highly contributes to trafficking
and homeostasis of human immune cells, stem cell
homing in tissue regeneration [13], but also tumorigen-
esis and progression of various types of cancer [14–16].
CXCR4 is prone to function in various homo- and het-
eromeric complexes to deploy its differential effects as
revealed by various crystal structures and additional
methods [17–19]. Importantly, CXCR4 has been associ-
ated with vGPCR-mediated manipulation of the chemo-
kine receptor homeostasis. The Epstein-Barr virus -
encoded vGPCR BILF1 was found to attenuate CXCL12-
induced CXCR4 signaling by scavenging Gαi-proteins
and impairing CXCL12 binding to CXCR4. Interestingly,
the G protein-coupling deficient mutant BILF1-K3.50A
affected CXCL12 - induced signaling less effectively, in-
dicating that BILF1 - mediated CXCR4 inhibition is a
consequence of its constitutive activity [20]. Addition-
ally, it was reported that the HCMV - encoded vGPCRs
UL33 and UL78 modulate CXCR4 signaling, surface ex-
pression as well as its HIV coreceptor activity [3]. In
these reports, the observed manipulations of CXCR4 sig-
naling and surface expression were mainly attributed to
a direct physical contact or heteromerization of CXCR4
with the viral GPCRs BILF1, UL33 and UL78.
As GPCRs can physically affect each other’s signaling
by forming heteromeric complexes [21], we thoroughly
investigated the possibility of physical interaction or het-
eromerization of the vGPCR US28 with the human che-
mokine receptor CXCR4. Indeed, US28 seems to employ
a subtler but nevertheless very effective way to influence
CXCR4 signaling. Our data support the assumption that
the observed attenuation of the CXCR4 surface expression
and signaling in the presence of US28 is partly attributed
to the high constitutive activity of US28. We believe that
the G protein-dependent constitutive signaling of US28
leads to indirect signaling crosstalk via shared intracellular
signaling networks, which results in disturbed chemokine
receptor signaling and reduced surface expression.
Results
US28 abates chemokine-induced G protein-mediated
signaling of CXCR4
CXCR4 is a Gαi/o protein-specific receptor [22]. Upon
binding and activation of CXCR4 by its endogenous lig-
and CXCL12, Gi/o proteins are activated, which results
in an inhibition of adenylate cyclase (AC) and subse-
quent reduction of intracellular cAMP levels. On the
contrary, US28 promiscously couples to different G pro-
tein subtypes from the Gαq/11, Gαi/o Gαs and Gα12/13
subfamilies [23–27]. US28 not only binds to several che-
mokines like e.g., RANTES (CCL5), MCP-1 (CCL2) or
Fractalkine (CX3CL1) with high affinity [7, 23, 28], but
is also highly constitutively active [28]. In order to assess
the effect of US28 expression on the CXCL12-induced
Gαi/o protein-dependent signaling of CXCR4, we moni-
tored the changes in cAMP levels by use of the BRET-
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based cAMP sensor CAMYEL. This biosensor is com-
prised of a catalytically inactive Epac1 that is fused to
Citrine at its N-terminus and to Renilla reniformis lucif-
erase (Rluc) at the C-terminus [29]. Binding of cAMP to
CAMYEL results in a conformational change in the
Epac1, which causes a decrease of BRET signal. In this
way we determined the basal and CXCL12-induced
changes in cAMP levels in presence and absence of
US28. To assess the influence of the constitutive activity
of US28 on CXCR4 signaling we included signaling-
impaired mutants of US28 (US28Δ300, US28DQY and
US28Δ300/DQY) in the assay. The US28DQY mutant
possesses a mutation R129Q that disrupts the DRY
motif. This leads to a loss of constitutive G protein acti-
vation [30]. The US28Δ300 mutant carries a truncated
C-terminus (the last 54 amino acids including important
serine and threonine residues were removed) and shows
slower constitutive endocytosis rates and increased consti-
tutive G protein signaling [30, 31]. The double mutant
US28Δ300/DQY combines both of these phenotypes. For
the assay HEK293T cells were transiently transfected with
CXCR4 and CAMYEL and stimulated with endogenous
chemokine ligand CXCL12. CXCL12 dose-dependently
decreased cAMP levels with a subnanomolar IC50 (Fig. 1a;
Table 1). Coexpression of US28wt or US28Δ300 with
CXCR4 significantly abated CXCL12-induced decrease in
cAMP levels to about 35% of the absolute efficacy ob-
served in mock-cotransfected cells (Fig. 1a; Table 1).
Moreover, the presence of US28wt or US28Δ300 induced
higher basal cAMP levels (Fig. 1a). As evident from
Additional file 1: Figure S1a, CXCR4 does not display
constitutive Gαi protein activation as the basal level of
cAMP in CXCR4-expressing cells was not different from
CAMYEL-sensor only expressing cells. In contrast, basal
cAMP levels in US28 expressing cells were increased to
the same level as observed for US28/CXCR4 coexpressing
cells. The G protein-uncoupled mutants US28DQY and
US28Δ300/DQY restored up to 75% of the agonist-
induced decrease in cAMP levels (Fig. 1a; Table 1) and did
not induce higher basal levels of cAMP. As the effect of
US28Δ300 on CXCR4 signaling was comparable to
US28wt and the double mutant US28Δ300/DQY did not
behave differently from US28DQY, the C-terminal domain
of US28 does not seem to be involved in modulation of G
protein-mediated signaling of CXCR4.
Fig. 1 The dampening effect of US28 expression on CXCR4 - induced G protein-dependent signaling is controlled by the DRY motif. a Changes in
agonist-induced cAMP concentrations after activation of CXCR4 were monitored in presence or absence of US28wt or US28 mutants. Cells were
treated with CXCL12 at indicated concentrations and 10 μM forskolin for 15 min before measurement. BRET ratios were normalized on signal from
mock-cotransfected cells stimulated with 100 nM CXCL12 (0%) or vehicle (100%). Curves represent means ± SEM of at least three independent
experiments performed in triplicates (n = 3–8). b Agonist-induced recruitment of Gαi1 to CXCR4 in presence or absence of US28 or US28 mutants. BRET
was measured in HEK293T cells cotransfected with CXCR4-Rluc8, Gαi1-91mVenus, Gβ1, Gγ2 and mock, US28wt or US28 mutants 2 min after addition of
100 nM CXCL12 or vehicle. ΔBRET was calculated by subtracting BRET ratios of vehicle-treated cells from BRET ratios of cells treated with 100 nM
CXCL12 for each individual transfection. Columns represent means ± SEM of three independent experiments performed in quadruplicates. Statistical
analysis was performed using one-way ANOVA with Dunnett’s post hoc test. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant
Table 1 Influence of US28 coexpression on efficacy and
potency of CXCL12-induced cAMP concentrations
Cotransfection Emax (mean ± SEM) pEC50 (mean ± SEM) n
CXCR4 +mock (control) 100 ± 4 9.85 ± 0.09 8
CXCR4 + US28 32 ± 11 (***) 9.54 ± 0.91 (n.s.) 4
CXCR4 + US28Δ300 35 ± 18 (***) 8.96 ± 1.10 (n.s.) 3
CXCR4 + US28DQY 73 ± 7 (n.s.) 10.02 ± 0.22 (n.s.) 5
CXCR4 + US28Δ300/DQY 76 ± 8 (n.s.) 10.34 ± 0.26 (n.s.) 4
Data shown correspond to Fig. 1a. Efficacy (Emax) is calculated as the absolute
value of the maximal CXCL12-induced effect normalized on CXCR4-only
expressing cells (100%). Potency is displayed as pEC50. Data were derived from
three to eight independent experiments each performed in triplicate wells and
are presented as mean ± SEM. Statistical analysis was performed using one-way
ANOVA with Dunnett’s post hoc test comparing US28 coexpressing systems
with CXCR4-only expressing cells (control). ***P < 0.001, n.s. not significant
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US28 affects interactions between Gi proteins and CXCR4
We also determined the effect of US28 expression on
the G protein-dependent signaling of CXCR4 as early as
on the level of Gαi1 protein recruitment. Therefore, we
again used a BRET-based method. Gαi1-91mVenus and
unlabeled Gβ1 and Gγ2 were coexpressed with CXCR4
carrying a Renilla reniformis luciferase 8 (Rluc8) at its
C-terminus [32]. The agonist-induced recruitment of the
Gαi1 subunit to the chemokine receptors was monitored
in presence and absence of US28wt or US28 mutants. In
CXCR4-expressing HEK293T cells, stimulation with 100
nM CXCL12 resulted in a significant increase in ligand-
promoted BRET signal (ΔBRET). In US28wt or US28Δ300
coexpressing cells Gαi1 recruitment to CXCR4 was sig-
nificantly reduced in efficacy, whereas the coexpression of
US28DQY or US28Δ300/DQY did not significantly sup-
press the agonist-induced Gαi1 protein recruitment to
CXCR4 (Fig. 1b). As evident from Additional file 1: Fig-
ure S1b, the maximal Gαi1 recruitment to CXCR4 in
presence of US28 does not increase with an increasing
pool of Gαi1 proteins, indicating that the recruitment of
Gαi1 proteins is not influenced by a limited pool of
Gαi1 proteins.
US28 restrains surface expression and CXCL12-mediated
β-arrestin 2 recruitment to CXCR4
A reduction of surface expression of chemokine receptors
CXCR4 as well as CCR1, CCR2 and CCR5 was observed
in monocytes upon their infection with endotheliotropic
strains (TB40E and VHLE) and clinical isolates of HCMV
[33]. This downregulation was attributed to a changed dis-
tribution between the cytoplasm and the cell membrane.
Also the coexpression of UL33 and UL78 vGPCRs
encoded by HCMV was shown to lead to altered surface
expression of chemokine receptors like CCR5 and CXCR4
[3]. As the reduced efficacy but not potency of G protein-
dependent signaling of CXCR4 in presence of US28 could
reflect a reduced number of available receptors on the cell
surface, we determined the effect of US28 on total and
surface expression of CXCR4. We initially used a whole-
cell radioligand-binding assay using either [125I]12G5 to
detect the surface expressed CXCR4 or [125I]CX3CL1/
Fractalkine to detect surface-expressed US28. The data
from this radioligand binding assay in COS-7 cells showed
that the coexpression of US28 with CXCR4 resulted in re-
duced binding of the radioligand without any effect on pKi
values (Table 2). This is indicative of a reduced number of
receptors expressed on the cell surface. The effect was re-
ciprocal – the expression of US28 resulted in a reduced
expression of CXCR4 and CXCR4 caused the reduced ex-
pression of US28 on the surface (Fig. 2a, b). To confirm
these observations, we performed an enzyme-linked im-
munosorbent assay (ELISA). With this assay we compared
the influence of wild type US28 and its signaling im-
paired mutants on the total and surface expression of
CXCR4. In the same assay the change in US28 expres-
sion and cellular distribution were monitored. The neu-
rotensin receptor type 1 (NTS1) was used as a negative
control for possible artifacts caused by transient expres-
sion of receptors. CXCR4 was FLAG-tagged, the US28
mutants and NTS1 were HA-tagged at the N-terminus
and transiently expressed in HEK293T cells at given
combinations (Fig. 2c-f ). To differentiate between the
surface and total expression, one set of probes was
permeabilized with TritonX-100 to detect the total
number of expressed receptors. Total expression of
CXCR4 was not significantly changed in all coexpres-
sion systems as analyzed by one-way ANOVA with
Dunnett’s post hoc test comparing coexpression sys-
tems with mock-transfection (Fig. 2d). As evident from
Fig. 2c, coexpression of US28wt reduced the surface ex-
pression of CXCR4 by up to 50%. Coexpression with
US28DQY or US28Δ300 still significantly reduced the
surface expression of CXCR4. Only when the double
mutant US28Δ300/DQY was coexpressed, CXCR4 sur-
face expression was not significantly altered, indicating
that the constitutive activity as well as the C-terminus
of US28 substitutably contribute to downregulation of
CXCR4 steady-state surface expression levels. Import-
antly, coexpression with NTS1 did not influence
CXCR4 surface expression, indicating that the observed
reduction in CXCR4 surface expression is not an
artifact of transient transfection but a direct result of
US28 coexpression. Additionally, we included US27,
another HCMV - encoded vGPCR, as a control. US27
is found predominantly in perinuclear vesicles like
US28 [34]. Moreover, US27 was described to upregulate
CXCR4 signaling as a result of increased CXCR4
Table 2 Radioligand-displacement studies to detect changes in CXCR4 and US28 surface expression





CXCR4 +mock (control) [125I]12G5 100 ± 2 8.13 ± 0.07 7
CXCR4 + US28wt [125I]12G5 74 ± 5 (***) 8.27 ± 0.26 (n.s.) 7
US28wt +mock (control) [125I]CX3CL1 99 ± 3 8.82 ± 0.08 7
US28wt + CXCR4 [125I]CX3CL1 70 ± 10 (*) 8.71 ± 0.43 (n.s.) 7
Data presented are derived from seven independent experiments, each performed in duplicate wells, presented as mean ± SEM. Statistical analysis was performed
using Student’s t test, comparing coexpression with mock-cotransfection (control). *P < 0.05; ***P < 0.001, n.s. not significant
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protein expression levels [35]. We could reproduce this
upregulation of total CXCR4 expression levels (Add-
itional file 2: Figure S2). In contrast to US28, US27 does
not alter the distribution of CXCR4 between plasma
membrane and cytoplasm. This further underlines the
hypothesis that the HCMV - encoded vGPCRs interfere
with the chemokine receptor system in multiple ways.
In contrast to data from the whole-cell radioligand-
binding assay, we found the total and surface expres-
sion of US28wt and mutants to be unaltered in the
presence of CXCR4 (Fig. 2e, f ). As a result of slower re-
cycling rates the US28Δ300 and US28Δ300/DQY were
expressed on the cell surface to a higher extent than
US28wt and US28DQY, as described before [36].
As phosphorylation by G protein-coupled receptor ki-
nases (GRKs) and subsequent recruitment of β-arrestins
Fig. 2 Analysis of CXCR4 and US28 total and surface expression in mono-and coexpressing cells. a, b Radioligand-displacement studies to detect
changes in CXCR4 and US28 surface expression were performed in transiently transfected COS-7 cells. Dose response curves represent the means
± SEM of seven independent experiments, each performed in duplicate. c-f For the ELISA - based analysis N-terminally FLAG-tagged CXCR4 and
N-terminally HA-tagged US28, US28mutants and NTS1 were expressed in HEK293T cells. c Surface expression of CXCR4 was calculated as the
signal ratio between permeabilized and non-permeabilized cells (reflected by FLAG-immunoreactivity) and normalized on the surface expression
in CXCR4-only expressing cells. d The total expression of CXCR4 in mono- and coexpressing cells was calculated as a factor of FLAG-immunoreactivity
in mock-transfected cells. e Surface expression of US28, US28 mutants and NTS1 in presence and absence of CXCR4 was calculated as the signal ratio
between permeabilized and non-permeabilized cells (reflected by HA-immunoreactivity). f The total expression of US28, US28 mutants and NTS1 in
presence and absence of CXCR4 was calculated as a factor of HA-immunoreactivity detected in mock-transfected cells. Columns represent means ±
SEM from at least three independent experiments (n = 3–5), each performed in triplicates. Statistical analysis was performed using one-way ANOVA
with Dunnett’s post hoc test. (*P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant)
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are employed by CXCR4 as a mechanism of desensitization,
we also investigated the influence of US28wt and mutants
on agonist-induced β-arrestin 2 recruitment to CXCR4. For
this assay we used a β-arrestin 2 construct carrying Renilla
reniformis luciferase 2 (RlucII) at the N-terminus and
CXCR4 carrying mVenus at its C-terminus. We then moni-
tored the β-arrestin 2 recruitment to CXCR4 in presence
and absence of US28wt and mutants. The coexpression
of US28wt with CXCR4 almost completely abolished
agonist-induced β-arrestin 2 recruitment to CXCR4.
The coexpression of mutants US28Δ300 or US28DQY
did not significantly restore the β-arrestin 2 recruit-
ment to CXCR4 (Fig. 3a). Only the coexpression with
US28Δ300/DQY led to partial restoration of agonist-
induced β-arrestin 2 recruitment to CXCR4.
To validate our data obtained in the BRET-based β-
arrestin 2 recruitment assay, we employed a biolumines-
cence complementation (BiLC)-based system developed
by Ozawa et al. [37, 38]. They optimized the comple-
mentation of split luciferase fragments from click beetle
(Brazilian pyrearinus termitilluminans) to provide a
BiLC-system with high sensitivity and low signal-to-
noise ratio. As shown in Fig. 3b, the data obtained from
BiLC-based β-arrestin 2 recruitment are comparable to
the data from the BRET-based approach. Additionally,
we verified that the attenuation of β-arrestin 2 recruit-
ment to CXCR4 in the presence of US28wt is not caused
by a limited pool of β-arrestin 2 available for the inter-
action. As shown in Additional file 3: Figure S3, the re-
duction of β-arrestin 2 recruitment to CXCR4 in
presence of US28wt is not influenced by an increasing
pool of β-arrestin 2.
CXCR4 does not heteromerize with US28
Among GPCR researchers there is an ongoing debate
about the existence and importance of GPCR dimers in
vivo. However, several reports showed the organization
of class A GPCRs in homodimeric, oligomeric or even
heteromeric complexes [21, 39–41]. Methods such as
pull-down assays, protein crystallography, BRET, fluores-
cence resonance energy transfer (FRET), fluorescence re-
covery after photobleaching (FRAP) and single molecule
imaging provide tools to track GPCR dimerization in liv-
ing cells [42–45]. Also bitopic ligands are important
tools to analyze and manipulate receptor dimerization
[46].
Initially, we used BiLC-technology to study
dimerization of CXCR4 and US28. For this purpose, we
created necessary expression vectors for C-terminally
tagged receptors using previously described splits of
Renilla reniformis luciferase 8 (Rluc8) [31]. As a control
for nonspecific interactions, we used CD86, which is
known to behave as a monomer and is routinely used as a
monomeric control protein in studies of e.g., dimerization
of GPCRs [43, 47, 48]. As expected, the strongest signal
was obtained in the case of CXCR4 homodimers, which is
in accordance with the literature reporting homodimeriza-
tion and oligomerization of CXCR4 [17, 49]. The lumines-
cence intensity at corresponding heterodimers indicated
the presence of weak heteromerization for US28-CXCR4
Fig. 3 Agonist-induced β-arrestin 2 recruitment to CXCR4 in presence and absence of US28wt and mutants. a BRET-based approach. CXCR4
C-terminally tagged with mVenus, β-arrestin 2 N-terminally fused to RlucII and US28, US28 mutants or empty vector (mock) were transiently
expressed in HEK293T cells. β-arrestin 2 recruitment was measured 5 min post-ligand addition. ΔBRET was calculated by subtracting BRET ratio
detected in vehicle stimulated cells from BRET ratio detected in CXCL12-stiumulated cells for each receptor-combination. Curves represent means
± SEM from at least three independent experiments (n = 3–6), each performed in triplicates. b BiLC-based approach. CXCR4 C-terminally tagged
with ElucC, β-arrestin2 N-terminally fused to ElucN and US28, US28 mutants or empty vector (mock) were transiently expressed in HEK293T cells.
Luminescence was measured following 10 min stimulation with 100nM CXCL12 or vehicle (no filters, 2 s recording). ΔLuminescence was calculated by
subtracting luminescence detected in vehicle stimulated cells from luminescence detected in cells stimulated with 100nM CXCL12 for each
transfection-combination and normalized on ΔLuminescence of mock-cotransfected cells. Columns represent means ± SEM from three independent
experiments, each performed in triplicates
Frank et al. Cell Communication and Signaling  (2016) 14:31 Page 6 of 16
(Fig. 4a). To estimate the reliability of our results, we also
used two similar BiLC-based approaches based on splits
of firefly and emerald luciferase [37]. As expected, the two
additional BiLC-based systems yielded comparable results
(Additional file 4: Figure S4). Because results from BiLC
are highly dependent on cell numbers and expression
levels, we further validated our observations by a BRET-
based assay, which enables differentiation between the real
dimerization and the false positive signal due to random
collision [44]. A constant amount of donor-labeled protein
is coexpressed with increasing amounts of acceptor-labeled
protein [39]. By plotting BRET ratios as a function of
acceptor/donor expression levels the specific signal can be
distinguished from unspecific signal. While a specific inter-
action is known to result in saturation of the BRET signal, a
nonspecific interaction yields a quasi-linearly increasing
BRET signal. For our experiments receptors were C-
terminally tagged with Rluc8 or mVenus. Donor saturation
curves were obtained by cotransfecting a fixed DNA
amount of receptor-RLuc8 in the presence of increasing
amounts of receptor-mVenus. As negative controls, a
homomeric pair of CD86 with the corresponding tags, as
well as cytoplasmic mVenus was used. A hyperbolic donor
saturation curve reaching an asymptote with increasing
mVenus/RLuc8 ratios was clearly observed for CXCR4
homodimers (Fig. 4b). For the negative controls, a linear in-
crease in net BRET was detected with increasing mVenus/
RLuc8 ratios, reflecting a nonspecific interaction because of
linearly increasing random collision. Low maximal BRET
(BRETmax) and high BRET50 values indicate low probability
for physical interactions between US28 and CXCR4
(Table 3). Moreover, the orientation of BRET sensors did
not influence this result, as the reciprocally tagged pair of
US28-CXCR4 yielded comparable results.
In order to additionally assess the subcellular localization
and colocalization of CXCR4 and US28 we investigated
transiently expressing C-terminally labeled receptors (ei-
ther with mCherry or eGFP) in HEK293T cells. As evident
from Fig. 5, CXCR4 is expressed mainly on the cell surface
whereas in turn US28 is found in intracellular vesicles.
Colocalization was weak and restricted to intracellular
vesicles.
Overall, BiLC and BRET results demonstrated that
US28 most likely does not form heterodimers with
CXCR4. Considering that also images from confocal
laser scanning microscopy showed that CXCR4 and
US28 only weakly colocalize and that this colocalization
is restricted to intracellular vesicles, we showed that
US28 does not influence CXCR4 signaling by heteromer-
ization. The localization of US28 in endosomes implies
that the effect of US28 on CXCR4 is ligand-independent.
US28 is involved in downregulation of CXCR4 in
HCMV-infected HUVEC
As we observed that the presence of US28 caused a
strong downregulation of CXCR4 from the cell surface
in HEK293T cells, which is connected with a drastic loss
of signaling ability, we next analyzed this interaction in
Fig. 4 Analysis of heteromerization between CXCR4 and US28 using BRET and BiLC. a BiLC using protomers of Rluc8 (Rluc8N/Rluc8C) to assess
receptor dimerization. Columns show the factor of Rluc8 activity measured in mock-transfected cells. Columns represent means ± SEM of at least three
independent experiments, each performed in triplicates. b BRET donor saturation curves by cotransfecting a fixed amount of receptor-Rluc8 in
presence of increasing amounts of receptor-mVenus constructs. net BRET was calculated by subtracting BRET ratio of donor-only expressing cells.
Curves represent pooled net BRET ratios (±SD) from three independent experiments, each performed in quadruplicates. Curves were fitted using least
square nonlinear regressions assuming a one site hyperbola. Data from negative controls were additionally fitted using linear regression
Table 3 BRETmax and BRET50 values (mean ± SEM) from BRET






CXCR4-Rluc8/CXCR4-mVenus 2.75 ± 0.042 0.11 ± 0.007 3
CXCR4-Rluc8/US28-mVenus 0.54 ± 0.031 0.24 ± 0.036 3
US28-Rluc8/CXCR4-mVenus 0.53 ± 0.023 0.33 ± 0.031 3
CD86-Rluc8/CD86-mVenus n.d. n.d. 3
CXCR4-Rluc8/cytopl. mVenus n.d. n.d. 3
Curves were fitted using nonlinear regression assuming a one-site hyperbola
Values are derived from pooled netBRET ± SD from three independent
experiments, each performed in quadruplicates
Legend: n.d. not to be determined
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the viral context. Therefore, we constructed a recombin-
ant virus TB40E/IE2eYFP-delUS28 which lacks the US28
gene and possesses an eYFP-tagged IE2 enabling detec-
tion of lytically-infected cells. The TB40E/IE2eYFP-
delUS28 and the previously described TB40E/IE2eYFP
[50] viruses allowed us to monitor CXCR4 surface
expression in lytically-infected cells via Fluorescence-
activated cell sorting (FACS) analysis. We infected pri-
mary human umbilical vein endothelial cells (HUVEC)
at a multiplicity of infection (MOI) of 2 which yielded
between 10 and 30% lytically-infected cells. We then
monitored CXCR4 surface expression in mock- and
lytically-infected cells at early (24 hpi) and late (96 hpi)
time points of infection. At 24 hpi, TB40E/IE2eYFP- and
TB40E/IE2eYFP-delUS28-infected HUVEC showed
strongly downregulated CXCR4 surface expression
(Fig. 6a). Strikingly, at 96 hpi CXCR4 surface expression
was significantly downregulated in TB40E/IE2eYFP-in-
fected HUVEC, whereas in TB40/IE2eYFP-delUS28-
infected HUVEC CXCR4 surface expression was re-
stored to mock level (Fig. 6b).
Discussion
In this study we show that expression of the cytomegalo-
viral chemokine receptor US28 leads to downregulation of
CXCR4 surface expression and agonist-induced signaling
in HEK293T cells. These findings are in accordance with
the observation that in primary HUVEC, infected with the
endotheliotropic TB40E strain of HCMV, CXCR4 is sig-
nificantly downregulated from the surface of infected cells.
In contrast, using a TB40E strain lacking the US28 gene
we detected that CXCR4 downregulation is strongly im-
paired, in particular at late times after infection indicating
an important role of US28 for CXCR4 modulation during
the course of HCMV infection.
We assessed the consequences of US28 expression for
the responsiveness of CXCR4 and could narrow down the
underlying mechanism to structural motifs of US28. Our
Fig. 5 Qualitative colocalization studies using confocal laser scanning microscopy. CXCR4 C-terminally fused to eGFP and US28 C-terminally
tagged with mCherry were coexpressed in HEK293T cells. Insets ROI 1 (e-h) and ROI 2 (i-l) show magnifications of the indicated areas in panels
(a-d). Cell nuclei were stained with DAPI. Scale bars in panels (a), (e) and (i) and represent 10 μm
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data demonstrate that the presence of US28 in CXCR4-
expressing cells leads to a dampening of CXCL12-induced
Gαi protein-dependent signaling. This inhibition could be
observed as early as on the level of Gαi protein recruit-
ment as well as on the level of the secondary messenger
cAMP. Additionally, US28 seems to antagonize the
ligand-induced Gαi1 recruitment of CXCR4 by its consti-
tutive G protein activation. The G protein-uncoupled mu-
tants US28DQY and US28Δ300/DQY had no significant
effect on agonist-induced second messenger formation
and Gαi protein recruitment of CXCR4, clearly showing
that mainly the DRY motif, enabling the high constitutive
activity of US28, is responsible for dampening of the G
protein-dependent signaling of CXCR4, while the C-
terminal domain does not seem to play a role.
The constitutive signaling activity of US28 attracted at-
tention before and is suspected to represent one of the
mechanisms employed by vGPCRs to disturb the host
immune homeostasis [28, 51]. US28 was reported to
constitutively activate phospholipase C-β (PLC-β) and
NFκB via Gq/11-dependent pathways [23, 52]. Infection
with US28R129A mutant virus failed to induce PLC-β
signaling, which also shows the clinical relevance of con-
stitutive G protein activation by US28 [53]. Moreover,
US28-mediated constitutive G protein activation is also
involved in tumor formation and progression [54]. The
C-terminally truncated forms of US28, lacking important
serine and threonine residues, are expressed to a higher
degree on the cell surface than US28wt and therefore
show even higher G protein-dependent constitutive ac-
tivity than wild type US28 [30]. This also explains the ef-
fect of the US28Δ300 mutant on Gαi protein-dependent
signaling of CXCR4 being comparable to US28wt.
Interestingly, in presence of US28wt, US28Δ300 and
US28DQY the CXCL12-induced β-arrestin 2 recruitment
to CXCR4 was abrogated. Only the concomitant
expression of US28Δ300/DQY led to partial recovery of
the initial agonist-induced β-arrestin 2 recruitment to
CXCR4. This indicates that the constitutive G protein ac-
tivation as well as the C-terminal phosphorylation sites of
US28 are involved in US28-promoted abrogation of β-
arrestin 2 recruitment to CXCR4, but are not the main de-
terminants. Recently, it was shown that activation of
ERK1/2 leads to a β-arrestin 2-dependent reduction of
constitutive GPCR cell surface expression and conse-
quently blunted G protein and β-arrestin signaling [55].
US28 was reported to activate ERK1/2 in an agonist-
dependent manner, engaging the G proteins Gαi1 and
Gα16, in response to RANTES/CCL5 [25]. As described
before, also an agonist-independent downstream activa-
tion of ERK1/2 can be observed in US28-expressing
HEK293T cells [56]. With use of the MEK1/2 inhibitor
PD184352 and the ERK1/2 inhibitor FR180204 we
intended to suppress US28-mediated ERK1/2 activation
and thus reduction of CXCR4 surface expression. How-
ever, this experiment did not reveal significant changes in
steady-state surface expression levels (data not shown).
Consequently, in case of US28, the weak constitutive acti-
vation of ERK1/2 via the Gq/11 pathway does not act as
the main determinant leading to the radical dampening of
CXCR4 signaling. US28 itself was shown to employ mul-
tiple routes for internalization including dynamin-
dependent pathways. However, US28 trafficking is not
dependent on β-arrestin, as in β-arrestin deficient cells
endocytosis and subcellular localization of US28 was un-
altered [57]. Nevertheless, the presence of US28 in
HEK293T cells was shown to cause a redistribution of β-
arrestin 2 from the plasma membrane to intracellular vesi-
cles in absence of ligand stimulation [58]. In contrast to
the G protein-uncoupled mutant US28R129A, a GRK
phosphorylation site-deficient mutant of US28, US28S1-
12A [59], showed the same effect on subcellular β-arrestin
Fig. 6 CXCR4 surface expression in infected HUVEC. At 24 and 96 hours post infection (hpi), mock- and TB40E/IE2eYFP- (wt) or TB40E/IE2eYFP-
delUS28- (ΔUS28) infected HUVEC were examined by FACS for surface expression of CXCR4. Fluorescently labeled IE2-eYFP enabled detection of
CXCR4 surface expression in lytically-infected cells only. The percentages of HUVEC expressing CXCR4 were evaluated in mock- or lytically-
infected (IE2-positive) cells at 24 hpi (a) or 96 hpi (b). Values are the mean ± SD of three experiments
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2 localization. This indicates that the DRY motif, con-
served in TM3 of US28 and responsible for constitutive
G protein activation, is sufficient to cause a redistribu-
tion of β-arrestin 2 to intracellular vesicles, which re-
duces its availability to interact with other receptors.
Still, the signaling-deficient US28DQY was not suffi-
cient to prevent abrogation of agonist-induced β-
arrestin 2 recruitment to CXCR4 in our hands. There-
fore, the mechanism of US28-mediated abrogation of
agonist-induced β-arrestin 2 recruitment to CXCR4 re-
mains to be unraveled.
As heteromerization is one of the mechanisms that en-
ables receptors to influence and disturb each other’s signal-
ing we also thoroughly investigated the possibility of
CXCR4/US28 heteromerization. However, our data indicate
that the observed dampening of CXCR4 responsiveness by
US28 cannot be explained by receptor heteromerization.
Data from BiLC and BRET saturation experiments suggest
a weak, most probably non-significant interaction between
CXCR4 and US28. Furthermore, qualitative analyses of im-
ages from colocalization studies using confocal laser scan-
ning microscopy show that CXCR4 does not colocalize
with US28 on the cell surface and intracellular colocaliza-
tion was confined to single vesicles.
We hypothesize that the attenuation of G protein- and
β-arrestin 2-dependent signaling of CXCR4 is related to a
reduced density of CXCR4 at the cell surface as we found
the surface expression of CXCR4 to be downregulated for
up to 50% in the presence of US28wt in HEK293T cells.
We observed that coexpression of the signaling-impaired
mutants US28Δ300 and US28DQY still significantly re-
duced CXCR4 surface expression. Only when the double
mutant US28Δ300/DQY was coexpressed, CXCR4 surface
expression was restored. This indicates that only when the
constitutive G protein signaling and the recycling-
machinery of US28 are impaired at the same time CXCR4
surface expression is not attenuated. However, we could
also show that not only in HCMV strain TB40E-infected
monocytes [33], but also in infected HUVEC CXCR4 sur-
face expression is significantly attenuated, which under-
lines the relevance of our study. We observed that TB40E/
IE2eYFP- and TB40E/IE2eYFP-delUS28-infected HUVEC
show strong downregulation of CXCR4 surface expression
at 24 hpi. At late time points of infection (96 hpi) CXCR4
surface expression was significantly downregulated in
TB40E/IE2eYFP-infected HUVEC, whereas in TB40E/
IE2eYFP-delUS28-infected HUVEC, CXCR4 surface ex-
pression was restored to mock level. This indicates that
US28 a critical factor involved in attenuation of CXCR4
surface expression in particular at late time points of in-
fection, which also correlates with the late expression kin-
etic of US28 [60]. The observed downregulation of
CXCR4 at early time points of infection is most probably
attributed to other factors. However, downregulation of
chemokine receptors in infected monocytes eventually im-
paired immune response to viral infection as shown by
Frascaroli et al. [33]. HCMV - infected monocytes failed
to recruit lymphocytes, monocytes and neutrophils as a
result of downregulated CCR1, CCR2, CCR5 and CXCR4
levels at the cell surface. Endothelial cells (EC) are de-
scribed to play a role in the dissemination of HCMV
throughout the body [61]. Interestingly, during acute dis-
ease EC can detach from the blood vessel and enter the
blood stream [62]. In contrast to detection of HCMV in-
fected EC during acute infection in immunocompromised
patients, their role during latency is controversial. There
are reports demonstrating HCMV DNA in vessel walls of
major arteries of sero-positive individuals [63], whereas
others classify EC as unlikely sites of HCMV latency in
vivo [64]. Downregulation of chemokine receptors from
the surface of EC might facilitate detachment of EC
from the blood vessel and entry into the blood stream,
thereby facilitating viral dissemination. In accordance
with reports about US28 being directly involved in fa-
cilitation of viral spread [60, 65], we propose that US28
might also indirectly promote viral dissemination by
downregulation of chemokine receptors from the sur-
face of infected cells.
Conclusion
In summary, our data support the assumption that the ob-
served attenuation of CXCR4 surface expression and sig-
naling in presence of US28 is mainly caused by the high
constitutive activity of US28. By use of well-characterized
mutants of US28, we could attribute the reduction of G
protein-dependent signaling and surface expression of
CXCR4 to an activity relying partially on the DRY motif
and C-terminus of US28. We propose that the constitutive
signaling of US28 leads to indirect signaling crosstalk via
shared intracellular signaling networks. This eventually re-
sults in disturbed chemokine receptor signaling and re-
duced constitutive surface expression, which is also
reflected in HCMV-infected primary HUVEC.
Methods
Cell culture and transfection
Human Embryonic Kidney 293 (HEK293) T cells were
cultured in DMEM/F-12 supplemented with 10% (vol/vol)
fetal bovine serum (FBS), 1% penicillin-streptomycin,
2 mM L-glutamine and incubated at 37 °C/5% CO2. Tran-
sient transfections were performed using linear polyethy-
lenimine 25 kDa (PEI) (Polysciences, Inc.) or TransIT-293
transfection reagent (Mirus corporation) as transfection
reagent at a transfection reagent/DNA ratio of 3:1. COS-7
cells were grown in Dulbecco’s modified Eagle’s medium
1885 supplemented with 10% FBS, 2 mM glutamine, 180
units/ml penicillin and 45 μg/ml streptomycin at 37 °C/
10% CO2. Primary human foreskin fibroblasts (HFFs) were
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prepared from human foreskin tissue [66] and cultured in
Eagle’s minimal essential medium supplemented with
7.5% FBS, 1% L-glutamine and gentamicin at 37 °C/5%
CO2. Primary HUVEC (a kind gift from M. Mach,
Erlangen, Germany) were isolated from single blood veins
from human umbilical cord tissue and cultured in Endo-
thelial Growth Medium supplemented with 5% FBS, hydro-
cortisone, human Fibroblast Growth Factor B (hFGF-B),
Vascular Endothelial Growth Factor (VEGF), human
insulin-like growth-factor-I (R3-IGF-1), ascorbic acid,
human epidermal growth factor (hEGF) and GA-1000
(Gentamicin, Amphotericin B) at 37 °C/5% CO2.
Virus infection
Infection experiments were performed with the recombin-
ant viruses TB40E/IE2-eYFP [50] and TB40E/IE2eYFP-
delUS28. Titration of the viral stocks was performed by
IE1p72 fluorescence [67]. Briefly, HFFs (8 × 104 cells) in
0.5 ml medium were seeded into 24-well plates and in-
fected the next day with 300 μl of various dilutions (1:5 to
1:55) of viral supernatant. At 2 hpi 500 μl of fresh culture
medium were added. At 36 hpi, cells were fixed with 4%
PFA and stained with monoclonal antibody p63-27, which
is directed against IE1p72 [68]. Subsequently, the number
of IE1-positive cells was determined in duplicate wells
and was used to calculate viral titers in IE1 protein-
forming units (IE1U) per ml. For infection, 2 × 105
HUVEC, between passage two and seven, were seeded
per well in 6-well plates. The day after, culture medium
was replaced by 2 ml of infectious cell culture su-
pernatant of TB40E/IE2-eYFP or TB40E/IE2-eYFP-
delUS28 and the plates were centrifuged for 30 min at
1900 × g. After 3 h of incubation, the supernatant was
substituted with fresh culture medium.
Generation of the recombinant virus TB40E/IE2eYFP-delUS28
For generation of the recombinant virus TB40E/IE2eYFP-
delUS28 the coding region of US28 was removed from the
already described HCMV TB40E/IE2eYFP [50] by BAC
(bacterial artificial chromosome) mutagenesis according
to Datsenko & Wanner [69]. E.coli strain DH10B, which
had beforehand been transformed with TB40E/IE2eYFP
BAC DNA and pKD46 (Red recombinase expression plas-
mid with a temperature sensitive, L-arabinose inducible
promoter) [69], were grown in LB medium supplemented
with chloramphenicol, ampicillin and 0.2% L-arabinose at
30 °C. In order to accomplish homologous recombination
E. coli cells were transformed with PCR fragments, gener-
ated by amplification of an FRT-kanamycin-FRT cassette
from plasmid pKD13 [69] using primers that are homolo-
gous to the adjacent regions of the US28 gene. DpnI was
added to digest template DNA and the amplicon was puri-
fied from an agarose gel. Positive transformants were
identified using agar plates containing chloramphenicol
and kanamycin at 37 °C and additionally checked for the
clearance of the Red recombinase plasmid pKD46 by use
of agar plates containing ampicillin. Subsequently, chlor-
amphenicol/kanamycin-resistant, but ampicillin-sensitive
clones were transformed with pcP20 in order to enable
elimination of the kanamycin cassette. pcP20 encodes for
a FLP recombinase expression plasmid, which is chloram-
phenicol/ampicillin-resistant and shows temperature-sen-
sitive replication and thermal induction of FLP
recombinase expression [70]. Chloramphenicol/ampi-
cillin-resistant mutants were selected at 30 °C and then
purified for pCP20 at 43 °C. Finally, chloramphenicol-
resistant but ampicillin/kanamycin-sensitive transfor-
mants were selected at 37 °C. BAC DNA was isolated
from bacteria and the obtained BACs were verified by
distinct PCR reactions and subsequent sequencing as
well as restriction fragment length polymorphism ana-
lysis (RFLP) as described previously [71]. In order to re-
constitute infectious particles, HFFs were transfected
with the obtained BAC DNA using X-tremeGENE
transfection reagent (Roche, Mannheim, Germany).
Cells were incubated until the appearance of distinct
cytopathic changes. Cell culture supernatant containing
infectious particles was harvested, centrifuged to re-
move cellular debris and stored at −80 °C until use.
Fluorescence-Activated Cell Sorting (FACS) analysis
For FACS analysis of TB40E/IE2eYFP or TB40E/
IE2eYFP-delUS28 infected cells HUVECs were harvested
at indicated time points post-infection using Accutase
Solution for 5–10 min at 37 °C. Cells were washed once
with PBS, followed by FBS-containing buffer (2% FBS
and 2 mM EDTA in PBS). Next, cells were stained with
anti-CXCR4-APC or anti-IgG2ab-APC antibodies in
FBS-containing buffer for 1 h at 4 °C. Finally, cells were
washed with FBS-containing buffer and fixed with 2%
PFA. Samples were analyzed with the BD LSR II Flow
Cytometer (BD Biosciences, Franklin Lakes, NJ, USA)
and the results were evaluated with FCS Express V3 (De
Novo Software, Los Angeles, CA, USA).
Plasmids
The cDNA encoding hCXCR4 was purchased from the
UMR cDNA Resource Center (University of Missouri-
Rolla, USA). The cDNA encoding US28wt and US27wt
receptor from TB40E strain of HCMV were used. BiLC:
Rluc8 plasmids: Rluc8 cDNA was provided by Jonathan A.
Javitch, Columbia University, USA. The used plasmids
were designed in accordance to the previously described
D2sR constructs [32]. The cDNAs encoding full-length
Rluc8 or fragments for the Rluc8N (residues 1–229) or
Rluc8C (residues 230–311) were fused to the C-terminus
of the respective receptors by a 24 aa linker in pcDNA5/
FRT (Invitrogen). Emerald luciferase (Eluc) and firefly
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luciferase (Fluc) split plasmids: The used plasmids were
designed in accordance to the described plasmids [37].
Fragments of Eluc, ElucN (residues 1–415) or ElucC (resi-
dues 394–542), were C-terminally linked to the respective
receptors by a 20 aa linker sequence (4 × SGGGG). Frag-
ments of Fluc, FlucN (residues 1–416) and FlucC (resi-
dues 416–550), were C-terminally linked to the respective
receptors by a 4 aa linker (SGGG). PCR products were
subcloned into pcDNA3.1(+) or pcDNA4/V5-His(B).
BRET sensors: CXCR4 was C-terminally fused to the YFP
derivative mVenus. G α i1-91mVenus was a gift from
Jonathan A. Javitch, Columbia University, USA. The Gβ1
and Gγ2 subunits as well as RlucII-β-arrestin 2 were
kindly provided by Michel Bouvier, University of Mon-
treal, Canada. The CAMYEL biosensor was purchased
from ATCC, USA. ELISA: CXCR4 cDNA was tagged by
N-terminally inserting a FLAG-tag (DYKDDDAAAD) im-
mediately before the start codon and cloned in pcDNA3.1.
The truncated version of US28wt, US28Δ300, was con-
structed by inserting a STOP-codon after residue Gln-
300. The DRY-lock mutant of US28, US28DQY, was
constructed by mutating the Arg in position 129 of the
DRY-motif to Gln as previously described [30, 31]. The
double mutant US28Δ300/DQY was constructed by
inserting a STOP-codon after residue Gln-300 of the
US28DQY mutant. US28wt, US28Δ300, US28DQY,
US28Δ300/DQY and NTS1 were N-terminally fused to
an HA-tag (YPYDVPDYA) in pcDNA3.1(+). The iden-
tity of all plasmids was confirmed by sequencing (LGC
Genomics).
Reagents, antibodies and radioligands
CXCL12 was purchased from PeproTech. Anti-HA, anti-
FLAG antibody and secondary peroxidase-conjugated
anti-IgG antibody for ELISA as well as Forskolin and
Accutase Solution were purchased from Sigma-Aldrich.
The anti-human CD184(CXCR4)-APC (clone 12G5) as
well as the isotype control anti-mouse IgG2ab-APC were
purchased from Miltenyi Biotec. Coelenterazin-h as well
as BrightGlo substrate were purchased from Promega.
Cell culture reagents for HEK293T, HFF and COS-7 cells
were purchased from Gibco/Thermo Fisher Scientific.
Medium growth factors for culturing HUVEC was pur-
chased from Lonza. The radiolabelled tracer of CX3CL1
was made by applying the oxidative iodination technique
to CX3CL1, which incorporates
125I at the meta-position
of tyrosine residue side chains, and the tracer was charac-
terized and purified by RP-HPLC [72]. The 12G5 tracer
was instead produced by Bolton-Hunter labelling, which
incorporates 125I at the amino terminus of the protein.
BiLC to assess receptor dimerization
HEK293T cells were transiently transfected in 96-well
plates with a pair of receptors fused to the C-terminal
(Cluc) and N-terminal (Nluc) split of Rluc8, Fluc or
Eluc, respectively using TransIT-293 transfection re-
agent, while the DNA ratio of receptor-Cluc:receptor-
Nluc was 1:1. Luminescence was measured 24 h after
transfection using the microplate reader Clariostar
(BMG Labtech, no emission filter, 2 s recording), follow-
ing the addition of 100 μl BrightGlo Substrate (Promega)
and 5 min incubation at RT.
BiLC to assess β-arrestin 2 recruitment
HEK293T cells were transiently transfected with ElucN-β-
arrestin 2, CXCR4-ElucC and US28, US28 mutants or
empty vector (mock) using PEI, while the DNA ratio was
2:1:1. At 48 hours post transfection (hpt), culture medium
was replaced by HBSS supplemented with 0.1% BSA. After
30 min incubation at 37 °C/5% CO2, cells were stimulated
with 100 nM CXCL12 or vehicle (HBSS-0.1%BSA). At
10 min post ligand addition, luminescence was measured
using the microplate reader Clariostar (BMG Labtech, no
emission filter, 2 s recording), following the addition of
100 μl BrightGlo Substrate and 5 min incubation.
Bioluminescence resonance energy transfer
measurements
In this study, BRET480-YFP also termed BRET
1 was used
for all the following described BRET-based assays. For
BRET1, one of the proteins is fused to Rluc or brighter
forms of Rluc (RlucII/Rluc8) and the other protein is fused
to mVenus. Rluc and mVenus serve as energy donors and
acceptors, respectively. We used Coelenterazin-h (Pro-
mega) as a substrate for the luciferase, which generates
light with a maximal emission peak at 480 nm. The emis-
sion spectrum of Rluc overlaps with the excitation
spectrum of mVenus, which leads to energy transfer and
excitation of mVenus, if the two proteins are about less
than 10 nm apart from each other. For use of Rluc8 and
mVenus a Förster distance (R0) of 5.55 nm is described
[73]. R0 describes the intermolecular separation of donor
and acceptor which allows 50% of the maximal energy
transfer. BRET values were collected 5 min after addition
of Coelenterazin-h at a final concentration of 5 μM with
the microplate reader ClarioStar (BMG Labtech) equipped
with the BRET480-YFP filter set (475 ± 30 nm and 535 ±
30 nm). BRET ratio was determined as the ratio of the
emitted light by acceptor (filter: filter: 535 ± 30 nm) over
donor (475 ± 30 nm).
BRET titration curves to assess receptor dimerization
For BRET titration experiments a constant amount of
the receptor-Rluc8 plasmid (energy donor) was cotrans-
fected with increasing amounts of the receptor-mVenus
plasmid (energy acceptor) using PEI. At 2 d post trans-
fection, culture medium was replaced by HBSS comple-
mented with 0.1% BSA and cells were incubated for
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30 min at 37 °C/5% CO2 before measurement of BRET.
To determine the specific BRET signal (net BRET), the
BRET signal detected in cells expressing the energy
donor only was subtracted from the BRET signal ob-
tained from cells expressing the acceptor and donor.
The net BRET values were plotted as a function of the ex-
pression level of the acceptor over the expression of the
donor for each individual transfection. The expression
level of the acceptor was determined by measuring mVe-
nus fluorescence (ex: 497 ± 15 nm, em: 535 ± 30 nm) and
the expression level of the donor was determined as emit-
ted light by the donor (filter 475 ± 30 nm).
BRET-based measurements of Gi protein activation
HEK293T cells were cotransfected with a beforehand op-
timized DNA ratio of CXCR4-Rluc8, Gαi1-mVenus, Gβ1,
Gγ2 and US28wt, US28 mutants or empty vector
(mock), whereas the DNA-ratio of CXCR4-Rluc8 to
US28, US28 mutant or empty vector was 1:1. Cells were
transfected using PEI and seeded in 96-well plates at a
density of 25,000 cells per well and incubated for 48 h.
For the assay, culture medium was replaced by HBSS
complemented with 0.1% BSA and cells were incubated
for 30 min at 37 °C/5% CO2. Cells were treated with
100nM CXCL12 or vehicle (HBSS-0.1% BSA) and BRET
was measured 2 min later. To determine the ligand-
promoted BRET signal (ΔBRET), BRET signal detected
in vehicle-treated cells was subtracted from BRET signal
detected in stimulated cells for each transfection.
BRET-based measurements of β-arrestin 2 recruitment
HEK293T cells were cotransfected with RlucII-β-arrestin
2, CXCR4-Rluc8 and US28, US28 mutants or empty vec-
tor (mock) whereas the CXCR4:US28 DNA ratio was 1:1.
Cells were transfected using PEI and seeded in 96-well
plates at a density of 25,000 cells per well and incubated
for 48 h. For the assay, culture medium was replaced by
HBSS complemented with 0.1% BSA and cells were incu-
bated for 30 min at 37 °C/5% CO2. BRET was measured
5 min after stimulation with endogenous ligands. To de-
termine the ligand-promoted BRET signal (ΔBRET), BRET
signal detected in vehicle-treated cells was subtracted
from BRET signal detected in stimulated cells for each
transfection.
BRET-based cAMP assay (CAMYEL-sensor)
HEK293T cells were cotransfected with chemokine recep-
tor cDNA and US28wt, US28Δ300 or US28DQY and
CAMYEL biosensor at a DNA ratio of 1:1:2 using PEI and
seeded into half-area 96-well plates at a density of 1,5 ×
104 cells per well. At 48 h after transfection, the culture
medium was removed and replaced by HBSS complemen-
ted with 0.1% BSA and incubated for 30 min at 37 °C/
5%CO2. BRET values were collected 15 min after
simultaneous treatment with indicated concentrations of
CXCL12 and a final concentration of 10 μM Forskolin.
Confocal laser scanning microscopy
The day before transfection, HEK293T cells were seeded
in 6-well plates at a density of 2 × 105 cells/well. Cells
were transfected with C-terminally eGFP-tagged CXCR4
and C-terminally mCherry-tagged US28 or empty vector
(mock) using TransIT293(MIRUS). Cells were trans-
ferred to Poly-L-Lysine coated glass coverslips 24 h after
transfection. At 2 days after transfection, cells were
washed with PBS and fixed with 4% paraformaldehyde
(RotiHistofix,Carl Roth) for 10 min. After washing three
times with PBS, the glass coverslips were mounted on
microscope slides using Dako Fluorescent Mounting
Medium and investigated using a Leica SP5II confocal
microscope (Software LAS AF v2.7.3.9723) equipped
with Leica hybrid detectors. Excitation energy and gain
were set to the same level to make all data set-ups com-
parable in intensity. Microscopy/Image analysis was per-
formed with support from the Optical Imaging Center
Erlangen (OICE). Post image processing (adjusting
brightness and contrast) was performed for a better
visualization.
Enzyme linked immunosorbent assay (ELISA)
HEK293T cells were transiently cotransfected with Flag-
tagged chemokine receptors and HA-tagged US28 wild-
type or mutants or empty vector (mock) at a DNA ratio
of 1:1. 24 h after transfection, cells were seeded in Poly-
D-Lysine-coated 48-well plates. At 48 hours post trans-
fection the cells were fixed with 4% PFA for 10 min at
RT. Cells were permeabilized or not for 5 min in PBS/
0.1% TritonX-100 at RT. In separate wells, cells were
stained with monoclonal anti-Flag or anti-HA antibody
produced in mouse followed by an anti-mouse, IgG-
peroxidase conjugated antibody. Absorbance at 492 nm
was measured 10 min after incubation in substrate buffer
containing 6 mM o-phenylenediamine using the micro-
plate reader ClarioStar (BMG LabTech).
Data and statistical analysis
All graphs were generated and analyzed using PRISM
6.0 (GraphPad Software, San Diego, CA). Curves were
fitted using least square nonlinear regressions assuming
a one site hyperbola where Kd corresponds to BRET50
and Bmax corresponds to BRETmax or linear regression
(BRET saturation experiments) or sigmoidal fit (dose-re-
sponse curves), in which the logIC50 and Hill coefficient
were free parameters. Statistical analysis was performed
using one-way ANOVA with Dunnett’s post hoc test if
more than two values were compared with the control
or Student’s t test if two values were compared.
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Radioligand competition binding assay
Two days before the assays, the calcium phosphate pre-
cipitation method was used to transiently transfect cells
with pcDNA3.1(+) vectors expressing either CXCR4 or
US28, and on the next day, the transfected cells were
seeded to 96-well plates. For the competition binding as-
says, the cells were washed in HEPES buffer (50 mM) sup-
plemented with BSA (5 g/l) and chilled at 5 °C. Unlabeled
ligands were added to the cells 5 min before adding the
tracer, which was administered at levels leading to 10%
tracer binding. Following an incubation period of 3 h at 4 °
C, the cells were washed in HEPES buffer with BSA (5 g/l)
and NaCl (29.22 g/l) to remove any unbound tracer, and
gamma radiation of the remaining tracer was measured.
Additional files
Additional file 1: Figure S1. Influence of the constitutive activity of
US28 on Gαi/o protein-dependent signaling of CXCR4 (a) Basal and
CXCL12-induced changes in cAMP levels in CXCR4/US28 coexpressing,
CXCR4-only, US28-only or CAMYEL sensor-only expressing HEK293T cells.
Data were normalized on signal from mock-cotransfected cells stimulated
with 100 nM CXCL12 (0%) or vehicle (100%). Curves represent means ±
SEM from three independent experiments, each performed in triplicate
wells. (b) For each transfection, 3 × 105 HEK293T cells were transfected
with 1 μg cDNA, while amounts of cDNA for CXCR4-Rluc8 US28wt was
fixed and the DNA amount for Gα i1-mVenus was gradually increased.
After stimulation with vehicle or 100 nM CXCL12, BRET was measured.
ΔBRET was calculated by subtracting BRET ratios of vehicle-treated
cells from BRET ratios of cells treated with ligand for each individual
transfection. Comment on Additional file 2: Figure S2b: Data in Fig. 1b
was generated using a ratio of 1:1:20 (15 ng:15 ng:300 ng) of CXCR4-
Rluc8:US28wt:Gαi1-mVenus. We titrated the amount of cDNA for Gαi1-
mVenus and observed that at a ratio of 1:1:10 the recruitment of Gαi1
to CXCR4 is saturated and does not increase with further increasing
concentrations of Gαi1-mVenus. (TIF 152527 kb)
Additional file 2: Figure S2. US27 does not alter surface expression of
CXCR4 in HEK293T cells. HEK293T cells were cotransfected with CXCR4,
N-terminally tagged with FLAG, and mock or US27wt (a) Surface expres-
sion of CXCR4 was calculated as the signal ratio between permeabilized
and non-permeabilized cells (reflected by FLAG-immunoreactivity) and
normalized on the surface expression in CXCR4-only expressing cells. (b)
The total expression of CXCR was calculated as a factor of FLAG-
immunoreactivity in mock-transfected cells. (TIF 138263 kb)
Additional file 3: Figure S3. β-arrestin 2 pool titrations. HEK293T cells
were cotransfected with fixed amounts of CXCR4-ElucC and mock (a) or
US28wt (b) cDNA and the DNA amount for ElucN-β-arrestin 2 was increased.
After stimulation with vehicle or 100 nM CXCL12, luminescence was
measured. ΔLuminesence was calculated by subtracting luminescence
detected in vehicle stimulated cells from luminescence detected in cells
stimulated with ligand for each transfection. Columns represent means
± SEM of at least two independent experiments each performed in
quadruplicates. (TIF 130557 kb)
Additional file 4: Figure S4. Assessment of receptor homo- and
heterodimerization using firefly luciferase (Fluc) and emerald luciferase
(Eluc) splits. Receptors carrying splits of Fluc (FlucN/FlucC) (a) or Eluc
(ElucC/ElucN) (b) at their C-terminus were used. Columns represent
mean ± SEM from at least four independent experiments (n = 4–6),
each performed in quintuplicates. Measured luminescence is represented as
a factor of signal from mock-transfected cells. (TIF 131059 kb)
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